Actively Recruiting
Effectiveness and Cost-effectiveness of PelviSense, a Novel Biofeedback Device for Stress Urinary Incontinence in Women
Led by The Hong Kong Polytechnic University · Updated on 2025-03-17
142
Participants Needed
2
Research Sites
134 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Aims: (1) Investigate the efficacy of PelviSense-assisted PFMT compared with PFMT alone for improving SUI symptom severity in women; (2) Compare the cost-effectiveness of the PelviSense device against PFMT alone for treating SUI in women; (3) Explore the views of women regarding the use of the PelviSense device as an adjunct to PFMT and the impacts of the PelviSense device on their lives and well-being. Design and subjects: A sequential, embedded, experimental mixed-methods design, including a randomised controlled trial (RCT) and semi-structured focus groups, will be conducted alongside an economic evaluation. The proposed study will include 142 women with SUI or stress-predominant mixed urinary incontinence. Interventions: Women will be randomly allocated to one of two groups (PelviSense or PFMT alone \[control\]). The PelviSense group will perform PFMT with assistance from the PelviSense device, and the control group will perform PFMT without biofeedback (i.e., PFMT alone). Outcome measures: International Consultation on Incontinence Questionnaire-Short Form, one-hour pad test, Modified Oxford Scale, EQ-5D-5L, and electronic cost diary. Data analysis and expected results: Statistical analysis will be conducted using analysis of covariance. The PelviSense group is expected to report significant improvements in primary and secondary outcomes compared with the PFMT alone group. The PelviSense group will yield cost savings and result in lower health care utility compared with the PFMT alone group.
CONDITIONS
Official Title
Effectiveness and Cost-effectiveness of PelviSense, a Novel Biofeedback Device for Stress Urinary Incontinence in Women
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-pregnant women with stress urinary incontinence (SUI)
- Aged 35 to 65 years
- Experiencing mild to moderate SUI indicated by a 1-50 g pad weight gain during a 1-hour pad test with stress
- Mini-Mental State Examination score of 24 or higher
You will not qualify if you...
- Women less than 6 months postpartum
- Women with severe pelvic organ prolapse
- Women with complicated SUI due to pelvic region radiation
- Women with a body mass index (BMI) of 30 or higher
- Women with severe psychological problems impairing study participation
- Women with mixed urinary incontinence (MUI) or urge urinary incontinence (UUI)
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Hong Kong Polytechnic University
Hong Kong, Hong Kong, 999077
Actively Recruiting
2
Kwong Wah Hospital
Kowloon, Hong Kong
Actively Recruiting
Research Team
P
PRIYA KANNAN, PhD
CONTACT
B
Brigitte Kim Yook Fung, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here